Recommended Global Pharmaceutical Sciences Webinars & Conferences
Europe & UK
Asia Pacific & Middle East
Nano Delivery 2020
Conferenceseries LLC Ltd is a renowned organization that organizes highly notable conferences throughout the globe. Currently we are bringing forth “European Congress on Nanomedicine and Drug Delivery Systems” (Nano Delivery 2020) scheduled to be held during December 07-08, 2020 at Paris, France. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Nanomedicine & Drug Delivery Systems.
The main theme of the conference is “Nanomedicine: Shaping the future of next generation medicine”.
Conferenceseries LLC Ltd organizes a conference series of 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Nano Delivery 2020 aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Nanotechnology and Nanomedicine. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Nanomedicine, Nanotechnology and Drug Delivery.
Medicine has developed throughout time but has remained forever concerned with the maintenance of health and thus the science of prevention and alleviation, and ultimately curing, of disease. To continue its development in new directions, medicine is now looking to nanomedicine, an emerging scientific specialty born from nanotechnology, which has grown up in the fields of engineering, physics, chemistry and biotechnology, and is now moving into medicine, with huge potential for expansion and development over the next decade and beyond.
As our knowledge of the human body continues to improve, nanotechnology will be developed to monitor, repair and control human biological systems at the molecular level. This conference will offer unique opportunities for developing new therapeutic approaches to diagnose, prevent, treat and eradicate life-threatening diseases and conditions (such as cancer and diabetes), as well as resolving pain and improving medical techniques (such as bone repair and surgical techniques), through various novel nanotechnological approaches.
Nanomedicine is a uniquely addressing the important challenges and advances in medical nanoscale-structured material and devices, biotechnology devices and molecular machine systems and nanorobotics. Nano Delivery 2020 is a valuable information source for all players in the field – academic, industrial and clinical researchers, pharmaceutical and biotechnology companies, regulatory authorities and others across the scientific community.
Why to attend:
Get into the depth of why methods for formulating and delivery strategies fail.
Identify how advancements in the pharmaceutical industry influence medical products with large and small molecules.
Think on how to build the best formulation and distribution approach from a deep healthcare, science and business mind set in a rational manner.
Discover the latest drug delivery systems technologies.
Who you will meet?
Chance to meet Leaders in
- Drug Delivery
- Drug Development
- Process R&D
- Bio manufacturing
- Delivery Devices
- Analytical Development
- New Products
Sessions and Tracks
- Cancer and Nanotechnology
Nano pharmaceutics and medication distribution has a wide demand in Europe. Drug delivery technology has evolved amazingly to advanced levels, from simplistic drug reformulation and release technologies. Throughout the projected era, the Nano robotics market is expected to expand at the fastest CAGR in Europe. Here the fast demand growth can be traced to the increased ageing population and the rise in governmental healthcare expenditure. Also, Europe was among the most extreme areas for understanding Nano robotics ability.
The production and formulation of drugs will show slow and stable growth of 20.7%. Nanoparticles will continue to exhibit stable development at 20.1% for their use in diagnostic imaging. It is estimated that the global demand for Nano devices and Nano machines will rise from $736.1 million in 2018 to $1.3 billion in 2023 and then to $2.7 billion in 2028, at an average annual growth rate (CAGR) of 11.6% in 2018 to 2023 and 16% from 2023 to 2028, and 16.0 per cent. It is estimated that the global demand for Nano-pharmaceutical drugs will rise over $79.29 billion by 2026, with a CAGR of 8.12 percent from 2018 to 2026.
It is estimated that Nanomedicine and Advanced Drug Delivery's combined market value will be $755.3 billion, with a 60/40 split between Nanomedicine and advanced drug delivery. Besides that, the creation of new tailored distribution mechanisms can generate more value for businesses and entrepreneurs.
This research estimates Revenue growth at regional & country level and offers an overviewof the emerging developments and opportunities between 2013 and 2025 in each of the sub-segments.Grand View Research has segmented the nanomedicine market basedon drug, application, nanomolecule size, and regions for this research.
Key companies in the European drug delivery technology market:
3M Company (U.S.)
Aptalis Pharma, Inc. (U.S.)
Baxter International, Inc. (U.S.)
Becton Dickinson & Co. (U.S.)
Catalent Pharma Solutions (U.S.)
The Dow Chemical Company (U.S.)
Endo Pharmaceuticals (U.S.)
Johnson & Johnson (U.S.)
Nektar Therapeutics (U.S.)
SkyePharma PLC (U.K.)
Ypsomed Holding AG (Switzerland)